Gabbi

Gabbi, Inc.Founded in 2019 and headquartered in Portland, US, Gabbi, Inc. provides a clinically-validated online platform that helps women assess their breast cancer risk.Gabbi's main offerings center around a clinically-validated online risk assessment tool designed for women to evaluate their risk of breast cancer and understand contributing factors. The platform facilitates virtual consultations with specialized nurse practitioners who develop personalized care plans, order necessary tests or imaging, and provide follow-up support. This service aims to streamline the path for women from initial risk assessment to appropriate care, significantly reducing the time to diagnosis and intervention. Gabbi primarily serves health systems, employers, and individual patients across the United States, focusing on early detection and preventive care for breast cancer.Gabbi generates revenue through partnerships with health systems and employers, facilitating a B2B model that supports early breast cancer detection among employees and patients. The company employs a subscription-based model for health systems and employers, who pay for access to Gabbi's assessment tools and care coordination services. The revenue structure also involves direct-to-consumer transactions for individual patients seeking breast cancer risk assessments and care plans. The company aims to expand its services into additional geographic regions across the United States, enhancing its reach for breast cancer risk assessment solutions. Gabbi is also likely to enhance its platform by releasing new features aimed at improving user experience and health outcomes.

1. Seed

   Aug 9, 2022

   Amount

   $4.5M

   Investors

   Locked